R.H. Roth
About
R.H. Roth is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology.
According to data from OpenAlex, R.H. Roth has authored 134 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Cellular and Molecular Neuroscience, 49 papers in Molecular Biology and 32 papers in Neurology. Recurrent topics in R.H. Roth's work include Neuroscience and Neuropharmacology Research (56 papers), Neurotransmitter Receptor Influence on Behavior (48 papers) and Parkinson's Disease Mechanisms and Treatments (23 papers). R.H. Roth is often cited by papers focused on Neuroscience and Neuropharmacology Research (56 papers), Neurotransmitter Receptor Influence on Behavior (48 papers) and Parkinson's Disease Mechanisms and Treatments (23 papers). R.H. Roth collaborates with scholars based in United States, United Kingdom and Sweden. R.H. Roth's co-authors include John D. Elsworth, George K. Aghajanian, Michael J. Bannon, D. Eugene Redmond, B.S. Bunney, Jane R. Taylor, John R. Sladek, M. J. Kuhar, Nicholas J. Giarman and Beth L. Murphy and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.
In The Last Decade
R.H. Roth
134 papers receiving 8.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| R.H. Roth United States | 54 | 5.6k | 3.1k | 1.5k | 1.1k | 1.1k | 134 | 8.6k | ||
| Ben H.C. Westerink Netherlands | 56 | 6.3k 1.1× | 3.6k 1.2× | 1.3k 0.8× | 905 0.8× | 919 0.9× | 180 | 9.1k | ||
| T.H. Svensson Sweden | 45 | 5.2k 0.9× | 3.5k 1.2× | 1.2k 0.8× | 1.1k 0.9× | 523 0.5× | 136 | 7.6k | ||
| S.J. Enna United States | 58 | 6.8k 1.2× | 4.7k 1.5× | 986 0.7× | 1.8k 1.6× | 671 0.6× | 170 | 10.1k | ||
| Peter H. Kelly United States | 37 | 4.8k 0.9× | 2.3k 0.7× | 1.8k 1.2× | 807 0.7× | 625 0.6× | 74 | 6.5k | ||
| R.J. Naylor United Kingdom | 51 | 4.7k 0.8× | 2.8k 0.9× | 917 0.6× | 1.0k 0.9× | 791 0.7× | 174 | 8.1k | ||
| Françis C. Colpaert France | 53 | 6.0k 1.1× | 3.6k 1.2× | 1.1k 0.7× | 1.7k 1.6× | 851 0.8× | 237 | 9.0k | ||
| Agu Pert United States | 53 | 6.4k 1.1× | 4.5k 1.5× | 1.3k 0.8× | 1.5k 1.4× | 558 0.5× | 124 | 8.8k | ||
| Lewis S. Seiden United States | 56 | 8.3k 1.5× | 2.7k 0.9× | 1.6k 1.1× | 812 0.7× | 895 0.8× | 175 | 10.9k | ||
| L L Iversen United Kingdom | 32 | 5.1k 0.9× | 3.4k 1.1× | 939 0.6× | 1.8k 1.6× | 600 0.6× | 55 | 7.9k | ||
| Svante B. Ross Sweden | 48 | 4.8k 0.9× | 3.0k 1.0× | 739 0.5× | 876 0.8× | 542 0.5× | 230 | 7.4k |
Countries citing papers authored by R.H. Roth
Since
Specialization
Citations
This map shows the geographic impact of R.H. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.H. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.H. Roth more than expected).
Fields of papers citing papers by R.H. Roth
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by R.H. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.H. Roth. The network helps show where R.H. Roth may publish in the future.
Co-authorship network of co-authors of R.H. Roth
This figure shows the co-authorship network connecting the top 25 collaborators of R.H. Roth. A scholar is included among the top collaborators of R.H. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.H. Roth. R.H. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Morrow, Bret A., R.H. Roth, D. Eugene Redmond, & John D. Elsworth. (2011). Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease. Neuroscience. 189. 277–285.
2.
Hurley, Patrick J., et al.. (2011). Aged monkeys as a partial model for Parkinson's disease. Pharmacology Biochemistry and Behavior. 99(3). 324–332.
3.
Elsworth, John D., D. Eugene Redmond, Csaba Léránth, et al.. (2008). AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons. Experimental Neurology. 211(1). 252–258.
4.
Sladek, John R., Kimberly B. Bjugstad, Elizabeth A. Bundock, et al.. (2008). Embryonic Substantia Nigra Grafts Show Directional Outgrowth to Cografted Striatal Grafts and Potential for Pathway Reconstruction in Nonhuman Primate. Cell Transplantation. 17(4). 427–444.
5.
Elsworth, John D., et al.. (2007). Prenatal cocaine exposure enhances responsivity of locus coeruleus norepinephrine neurons: Role of autoreceptors. Neuroscience. 147(2). 419–427.
6.
Taylor, Jane R., John D. Elsworth, Matthew S. Lawrence, et al.. (1999). Spontaneous Blink Rates Correlate with Dopamine Levels in the Caudate Nucleus of MPTP-Treated Monkeys. Experimental Neurology. 158(1). 214–220.
7.
Morrow, Bret A., John D. Elsworth, Ann M. Rasmusson, & R.H. Roth. (1999). The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience. 92(2). 553–564.
8.
Morrow, Bret A., Jane R. Taylor, & R.H. Roth. (1995). Prior exposure to cocaine diminishes behavioral and biochemical responses to aversive conditioning: Reversal by glycine/N-methyl-d-aspartate antagonist co-treatment. Neuroscience. 69(1). 233–240.
9.
Collier, Timothy J., J.D. Elsworth, Jane R. Taylor, et al.. (1994). Peripheral nerve-dopamine neuron co-grafts in mptp-treated monkeys: Augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systems. Neuroscience. 61(4). 875–889.
10.
Kontur, Paul J., Mohammed S. Al‐Tikriti, Robert B. Innis, & R.H. Roth. (1994). Postmortem Stability of Monoamines, Their Metabolites, and Receptor Binding in Rat Brain Regibns. Journal of Neurochemistry. 62(1). 282–290.
11.
Redmond, D. Eugene, Richard J. Robbins, Frederick Naftolin, et al.. (1993). Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients.. PubMed. 71. 325–59.
12.
Taylor, Jane R., Valerae O. Lewis, John D. Elsworth, et al.. (1991). Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats. Psychopharmacology. 103(3). 407–414.
13.
Elsworth, John D., Ariel Y. Deutch, D. Eugene Redmond, John R. Sladek, & R.H. Roth. (1990). MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate. Neuroscience Letters. 114(3). 316–322.
14.
During, M J, Melvyn P. Heyes, Andrew Freese, et al.. (1989). Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic l-tryptophan loading. Brain Research. 476(2). 384–387.
15.
Bean, Andrew, Thomas E. Adrian, Irvin M. Modlin, & R.H. Roth. (1989). Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.. Journal of Pharmacology and Experimental Therapeutics. 249(3). 681–687.
16.
Elsworth, John D., Ariel Y. Deutch, D. Eugene Redmond, et al.. (1989). Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions. Neuroscience. 33(2). 323–331.
17.
Taylor, Jane R., et al.. (1988). Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology. 96(1). 121–134.
18.
Wolf, Marina E., Matthew P. Galloway, & R.H. Roth. (1986). Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.. Journal of Pharmacology and Experimental Therapeutics. 236(3). 699–707.
19.
Galloway, M P & R.H. Roth. (1983). Neuropharmacology of 3-isobutylmethylxanthine: effects on central noradrenergic systems in vivo.. Journal of Pharmacology and Experimental Therapeutics. 227(1). 1–8.
20.
Roth, R.H., et al.. (1980). Poststimulation catecholamine synthesis and tyrosine hydroxylase activation in central noradrenergic neurons. II. Depolarized hippocampal slices.. Journal of Pharmacology and Experimental Therapeutics. 212(1). 74–84.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ben H.C. Westerink Breakdown of academic impact, for papers by T.H. Svensson Breakdown of academic impact, for papers by S.J. Enna Breakdown of academic impact, for papers by Peter H. Kelly Breakdown of academic impact, for papers by R.J. Naylor Breakdown of academic impact, for papers by Françis C. Colpaert Breakdown of academic impact, for papers by Agu Pert Breakdown of academic impact, for papers by Lewis S. Seiden Breakdown of academic impact, for papers by L L Iversen Breakdown of academic impact, for papers by Svante B. Ross